Economic impact of inappropriate benzodiazepine prescribing and related drug interactions among elderly persons

Psychiatric Services

Volumn 64, Issue 4, 2013, Pages 331-338

  Dionne, Pierre Alexandre ^a   Vasiliadis, Helen Maria ^a   Latimer, Eric ^c   Berbiche, Djamal ^b   Preville, Michel ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b HÔPITAL CHARLES LEMOYNE   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; BUPRENORPHINE; CARBAMAZEPINE; CLARITHROMYCIN; CLOZAPINE; DIGOXIN; DILTIAZEM; ERYTHROMYCIN; FLUCONAZOLE; FLUOXETINE; FLUVOXAMINE; INDINAVIR; LORAZEPAM; OXAZEPAM; PHENYTOIN; RIFAMPICIN; RITONAVIR; TEMAZEPAM; TRAZODONE; TRIAZOLAM; VERAPAMIL;

AGED; ARTICLE; CANADA; CHRONIC DISEASE; COMMUNITY; DRUG COST; DRUG INTERACTION; DRUG MEGADOSE; DRUG UTILIZATION; EDUCATIONAL STATUS; EMERGENCY WARD; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL DISEASE; OUTPATIENT CARE; PUBLIC HEALTH SERVICE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SELF CONCEPT; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; BENZODIAZEPINES; CANADA; DRUG INTERACTIONS; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; INAPPROPRIATE PRESCRIBING; LOGISTIC MODELS; MALE; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES;

EID: 84883105227     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201200089     Document Type: Article

References (49)

1. Bogunovic OJ, Greenfield SF: Use of benzodiazepines among elderly patients. Psychiatric Services 55:233-235, 2004
2. Ashton H: The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry 18:249-255, 2005
3. Sramek JJ, Zarotsky V, Cutler NR: Generalised anxiety disorder: Treatment options. Drugs 62:1635-1648, 2002
4. Flint AJ, Gagnon N: Diagnosis and management of panic disorder in older patients. Drugs and Aging 20:881-891, 2003
5. Ciuna A, Andretta M, Corbari L, et al: Are we going to increase the use of antidepressants up to that of benzodiazepines? European Journal of Clinical Pharmacology 60:629-634, 2004
6. Bartlett G, Abrahamowicz M, Tamblyn R, et al: Longitudinal patterns of new benzodiazepine use in the elderly. Pharmacoepidemiology and Drug Safety 13:669-682, 2004
7. Kassam A, Patten SB: Hypnotic use in a population-based sample of over thirtyfive thousand interviewed Canadians. Population Health Metrics 4:15, 2006
8. Tu K, Mamdani MM, Hux JE, et al: Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. Journal of the American Geriatrics Society 49:1341-1345, 2001
9. Préville M, Vasiliadis HM, Bossé C, et al: Pattern of psychotropic drug use among older adults having a depression or an anxiety disorder: results from the longitudinal ESA study. Canadian Journal of Psychiatry 56:348-357, 2011
10. Morgan S, Raymond C, Mooney D, et al: The Canadian Rx Atlas, 2nd ed. Vancouver, British Columbia, University of British Columbia Centre for Health Services and Policy Research, 2008. Available at www.chspr.ubc.ca/pubs/atlas/ canadian-rx-atlas-2ndedition
11. Barbone F, McMahon AD, Davey PG, et al: Association of road-traffic accidents with benzodiazepine use. Lancet 352: 1331-1336, 1998
12. Woolcott JC, Richardson KJ, Wiens MO, et al: Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Archives of Internal Medicine 169: 1952-1960, 2009
13. Cumming RG, Le Couteur DG: Benzodiazepines and risk of hip fractures in older people: A review of the evidence. CNS Drugs 17:825-837, 2003
14. Zint K, Haefeli WE, Glynn RJ, et al: Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults. Pharmacoepidemiology and Drug Safety 19:1248-1255, 2010
15. Ben Amar M: The Polyconsumption of Psychotropic Drugs and the Principal Associated Pharmacologic Interactions [in French]. Montréal, Quebec Addiction Prevention Center, 2007
16. Stockley IH, Baxter K: Stockley's Drug Interactions: A Source Book of Interactions, Their Mechanisms, Clinical Importance and Management, 7th ed. London, Pharmaceutical Press, 2006
17. Flockhart DA: Drug interactions and the cytochrome P450 system: The role of cytochrome P450 2C19. Clinical Pharmacokinetics 29(suppl 1):45-52, 1995
18. Hanlon JT, Schmader KE, Ruby CM, et al: Suboptimal prescribing in older inpatients and outpatients. Journal of the American Geriatrics Society 49:200-209, 2001
19. Gaudet M, Tremblay E: Study of the Prevalence of Potentially Inappropriate Prescriptions Among the Elderly in Québec, 2000-2006 [in French]. Montréal, Quebec Drug Council, 2009. Available at collections.banq.qc.ca/ark:/52327/1944176
20. Mort JR, Aparasu RR: Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs 16:99-109, 2002
21. Drug Claims by Seniors: An Analysis Focusing on Potentially Inappropriate Medication Use, 2000 to 2006. Ottawa, Ontario, Canadian Institute for Health Information, 2007
22. Beers MH, Ouslander JG, Rollingher I, et al: Explicit criteria for determining inappropriate medication use in nursing home residents. Archives of Internal Medicine 151:1825-1832, 1991
23. Fick DM, Cooper JW, Wade WE, et al: Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Archives of Internal Medicine 163: 2716-2724, 2003
24. McLeod PJ, Huang AR, Tamblyn RM, et al: Defining inappropriate practices in prescribing for elderly people: A national consensus panel. Canadian Medical Association Journal 156:385-391, 1997
25. Gallagher P, Ryan C, Byrne S, et al: STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment): consensus validation. International Journal of Clinical Pharmacology and Therapeutics 46:72-83, 2008
26. Fialová D, Topinková E, Gambassi G, et al: Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293:1348-1358, 2005
27. Berdot S, Bertrand M, Dartigues J-F, et al: Inappropriate medication use and risk of falls-A prospective study in a large community-dwelling elderly cohort. BMC Geriatrics 9:30, 2009
28. Stockl KM, Le L, Zhang S, et al: Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. American Journal of Managed Care 16:e1-e10, 2010
29. Cahir C, Fahey T, Teeling M, et al: Potentially inappropriate prescribing and cost outcomes for older people: A national population study. British Journal of Clinical Pharmacology 69:543-552, 2010
30. Laroche ML, Charmes JP, Nouaille Y, et al: Is inappropriate medication use a major cause of adverse drug reactions in the elderly? British Journal of Clinical Pharmacology 63:177-186, 2007
31. van der Hooft CS, Schoofs MW, Ziere G, et al: Inappropriate benzodiazepine use in older adults and the risk of fracture. British Journal of Clinical Pharmacology 66: 276-282, 2008
32. Préville M, Boyer R, Grenier S, et al: The epidemiology of psychiatric disorders in Quebec's older adult population. Canadian Journal of Psychiatry 53:822-832, 2008
33. Chang C-B, Chan D-C: Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs and Aging 27:947-957, 2010
34. International Classification of Diseases, 9th rev.Geneva, WorldHealthOrganization, 2001
35. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994
36. Drummond MF: Methods for the Economic Evaluation of Health Care Programmes, 3rd ed. Oxford, United Kingdom, Oxford University Press, 2005
37. Rosenheck RA, Frisman LK, Neale MS: Estimating the capital component of mental health care costs in the public sector. Administration and Policy in Mental Health and Mental Health Services Research 21:493-509, 1994
38. Manning WG, Mullahy J: Estimating log models: To transform or not to transform? Journal of Health Economics 20:461-494, 2001
39. Cox BG, Cohen SB: Methodological Issues for Health Care Surveys. New York, Dekker, 1985
40. Trudel G, Courtemanche R, Tarte F: Validation, Coding, Entry and Weighting of Data for the Québec Health Survey, Technical Manual 87-07. Quebec, Government of Québec, Ministry of Health and Social Services, 1992
41. Aparasu RR, Mort JR, Brandt H: Psychotropic prescription use by communitydwelling elderly in the United States. Journal of the American Geriatrics Society 51:671-677, 2003
42. Gallagher P, O'Mahony D: STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers' criteria. Age and Ageing 37:673-679, 2008
43. Tillement JP, Albengres E, Cottin D, et al: The risk of falling due to benzodiazepine administration, alone or in combination, in elderly subjects [in French]. Therapie 56: 435-440, 2001
44. French DD, Chirikos TN, Spehar A, et al: Effect of concomitant use of benzodiazepines and other drugs on the risk of injury in a veterans population. Drug Safety 28: 1141-1150, 2005
45. Gurwitz JH, Rochon P: Improving the quality of medication use in elderly patients: A not-so-simple prescription. Archives of InternalMedicine 162:1670-1672, 2002
46. Steinman MA, Rosenthal GE, Landefeld CS, et al: Conflicts and concordance between measures of medication prescribing quality. Medical Care 45:95-99, 2007
47. Wang PS, Bohn RL, Glynn RJ, et al: Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. American Journal of Psychiatry 158:892-898, 2001
48. Préville M, Bossé C, Vasiliadis H-M, et al: Correlates of potentially inappropriate prescriptions of benzodiazepines among older adults: results from the ESA study. Canadian Journal on Aging 31:313-322, 2012
49. Tamblyn R, Lavoie G, Petrella L, et al: The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Québec. Journal of Clinical Epidemiology 48:999-1009, 1995